Preventing Stem Cell Transplant Complications With a Blood Separator Machine
Conditions: MDS (Myelodysplastic Syndrome); Myeloproliferative Disorder; Lymphoma, Non-Hodgkin; ALL (Acute B-Lymphoblastic Leukemia); AML (Acute Meylogenous LeukemiaIntervention: Device: Graft Manipulation (CD34+ Selection)Sponsor: National Heart, Lung, and Blood Institute (NHLBI)Recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Heart | Heart Transplant | Leukemia | Lung Transplant | Lymphoma | Research | Stem Cell Therapy | Stem Cells | Transplant Surgery | Transplants